Product Manual

_________
_
SofiaInflue
n
FORUSEWI
T
CLIACompl
e
Forinvitrou
ACertificate
laboratories
contact you
r
Medicarean
d
Failuretofol
meetingthe
INT
The Sofia I
n
nucleoprotei
directlyfro
m
diagnosisof
antigens.A
n
anFDAclea
r
andshould
n
Performanc
e
influenza vi
r
(VictoriaLik
e
Weekly Rep
o
Composition
emerginginf
If infection
w
criteria reco
m
controlprec
a
Viralculture
samples.
SUMMAR
Influenzavir
u
Influenzavir
u
viruses:A,B
,
TypeBvirus
e
been associ
a
simultaneou
s
_
________
_
n
zaA+BFIA
T
HSOFIAON
e
xity:Waived
seonly
ofWaiveris
that perfor
m
r
state healt
d
Medicaid
w
lowtheinstr
requirement
s
ENDEDU
S
n
fluenza A+
B
nantigensin
m
symptomat
i
acuteinflue
n
n
egativetest
r
edinfluenza
otbeuseda
s
e
characterist
r
uses A/Cali
f
e
)werethe
p
o
rt from th
e
of the 20
1
luenzavirus
e
w
ith a novel
m
mended b
y
a
utionsforn
o
shouldnot
b
Y
ANDEX
P
u
sesarecaus
u
sesareim
m
,
andC.Typ
e
e
sproducea
a
ted with a
s
ly,butusual
________
_
LY
requiredto
p
m
moderate
h departme
n
w
ebsiteatw
w
uctionsorm
o
s
forwaived
c
S
E
B
FIA emplo
y
nasalswab,
i
cpatients.T
n
zaAand in
f
ispresumpti
v
AandB mol
s
thesoleba
s
icsforinflue
n
f
ornia/7/200
p
redominant
e
CDC entitle
1
12012 Infl
u
e
s.
influenza vir
u
y
public heal
o
velvirulent
i
b
eattempted
P
LANATIO
ativeagents
m
unologically
e
A viruses a
diseasethat
large epid
e
lyonetypei
s
__
________
_

p
erformthis
a
nd high co
m
n
t. Addition
a
w
w.cms.hhs.g
o
o
dificationt
o
c
lassification
.
y
s immunofl
nasopharyn
g
hisqualitati
v
f
luenzaB vir
a
v
eanditisr
e
ecularassay
.
s
isfortreatm
n
zaAandB
w
9 (2009 H
1
influenzavir
u
d “Update:
u
enza Vacci
n
u
s is suspect
e
th authoriti
e
i
nfluenzavir
u
inthesecas
e
N
ofhighlycon
t
diverse,sing
rethe most
isgenerally
m
e
mic of hu
m
s
dominantd
u
_
________
_

testinaCLI
A
m
plexity test
l CLIA waiv
e
o
v/CLIAorfr
o
o
thetestsys
t
.
uorescence
g
ealswab,an
d
v
etestisinte
a
linfections.
e
commende
d
.
Negativere
s
e
ntorother
p
w
ereestablis
h
N1), A/Pert
h
u
sesincircul
a
Influenza A
c
n
e.” Perform
e
d based on
e
s, samples s
u
sesandsent
e
sunlessaB
t
agious,acut
e
lestranded
R
prevalentan
m
ilderthant
h
m
an disease
.
u
ringagiven
_
________
_

A
waivedset
t
t
ing. To obta
e
r informati
o
o
myourstat
e
t
eminstructi
o
to detect i
n
d
nasophary
n
ndedforus
e
Thetestis
n
d
theseresul
t
s
ultsdonot
patientman
a
h
edduringF
e
h
/16/2009 (
a
tionaccordi
c
tivity‐‐Unite
ance charac
t
current clini
hould be co
l
tostateorl
o
SL3+facility
e,viralinfec
t
R
NAviruses.
T
dareassoci
a
h
atcausedb
y
.
Both Type
season.
1
_
_________
_

t
ing.Thistes
t
in a Certific
a
o
n is availabl
e
healthdep
a
o
nswillresul
t
n
fluenza A
a
n
gealaspirat
e
e
asanaidin
n
otintended
t
sbeconfir
m
precludeinfl
u
a
gementdeci
e
bruarythro
u
(
H3N2), and
i
ngtotheM
o
d States, 20
teristics ma
y
cal and epid
l
lected with
o
calhealthd
e
isavailable
t
t
ionsofther
e
Thereareth
r
a
tedwith m
o
y
ty pe A.Typ
e
e
A and B
v
_
________
_
Pag
t
mayalsob
e
a
te of Waiv
e
l
e at the Ce
n
a
rtment.
t
inthetest
n
a
nd influenz
a
e
/washsamp
therapiddi
f
to detect in
f
m
edbyviral
c
u
enzavirusi
n
sions.
u
ghMarch2
0
B/Brisbane
/
o
rbidityand
M
102011 Sea
y
vary agai
n
emiological
s
appropriate
e
partmentfo
t
oreceivean
e
spiratorytr
a
r
eetypesof
i
o
stserious e
p
e
Cvirusesh
a
v
iruses can
_
______
e1of25
e
usedby
e
r, please
n
ters for
n
olonger
a
B viral
lestake n
f
ferential
f
luenzaC
c
ultureor
n
fections
0
11when
/
60/2008
M
ortality
son, and
n
st other
s
creening
infection
rtesting.
dculture
a
ct.
i
nfluenza
p
idemics.
a
venever
circulate

Summary of content (25 pages)